vs

Side-by-side financial comparison of Carnival (CCL) and Corteva (CTVA). Click either name above to swap in a different company.

Carnival is the larger business by last-quarter revenue ($6.3B vs $3.9B, roughly 1.6× Corteva). Carnival runs the higher net margin — 6.6% vs -14.1%, a 20.8% gap on every dollar of revenue. On growth, Carnival posted the faster year-over-year revenue change (6.6% vs -1.7%). Corteva produced more free cash flow last quarter ($4.2B vs $12.0M). Over the past eight quarters, Carnival's revenue compounded faster (8.2% CAGR vs -6.7%).

Carnival is the world's largest leisure travel group specializing in cruise operations. It owns multiple globally recognized cruise brands, serving millions of passengers yearly, offering all-inclusive vacation experiences covering accommodation, catering, entertainment, and shore excursions across global popular destinations.

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

CCL vs CTVA — Head-to-Head

Bigger by revenue
CCL
CCL
1.6× larger
CCL
$6.3B
$3.9B
CTVA
Growing faster (revenue YoY)
CCL
CCL
+8.3% gap
CCL
6.6%
-1.7%
CTVA
Higher net margin
CCL
CCL
20.8% more per $
CCL
6.6%
-14.1%
CTVA
More free cash flow
CTVA
CTVA
$4.1B more FCF
CTVA
$4.2B
$12.0M
CCL
Faster 2-yr revenue CAGR
CCL
CCL
Annualised
CCL
8.2%
-6.7%
CTVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCL
CCL
CTVA
CTVA
Revenue
$6.3B
$3.9B
Net Profit
$421.0M
$-552.0M
Gross Margin
42.4%
Operating Margin
11.6%
-13.6%
Net Margin
6.6%
-14.1%
Revenue YoY
6.6%
-1.7%
Net Profit YoY
38.9%
-1246.3%
EPS (diluted)
$0.33
$-0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCL
CCL
CTVA
CTVA
Q4 25
$6.3B
$3.9B
Q3 25
$8.2B
$2.6B
Q2 25
$6.3B
$6.5B
Q1 25
$5.8B
$4.4B
Q4 24
$5.9B
$4.0B
Q3 24
$7.9B
$2.3B
Q2 24
$5.8B
$6.1B
Q1 24
$5.4B
$4.5B
Net Profit
CCL
CCL
CTVA
CTVA
Q4 25
$421.0M
$-552.0M
Q3 25
$1.9B
$-320.0M
Q2 25
$565.0M
$1.3B
Q1 25
$-78.0M
$652.0M
Q4 24
$303.0M
$-41.0M
Q3 24
$1.7B
$-524.0M
Q2 24
$92.0M
$1.1B
Q1 24
$-214.0M
$419.0M
Gross Margin
CCL
CCL
CTVA
CTVA
Q4 25
42.4%
Q3 25
46.2%
37.2%
Q2 25
38.6%
54.6%
Q1 25
35.2%
47.0%
Q4 24
35.5%
37.3%
Q3 24
45.5%
32.7%
Q2 24
34.3%
52.3%
Q1 24
31.5%
43.2%
Operating Margin
CCL
CCL
CTVA
CTVA
Q4 25
11.6%
-13.6%
Q3 25
27.9%
-14.1%
Q2 25
14.8%
27.9%
Q1 25
9.3%
17.7%
Q4 24
9.4%
2.2%
Q3 24
27.6%
-27.2%
Q2 24
9.7%
21.9%
Q1 24
5.1%
10.7%
Net Margin
CCL
CCL
CTVA
CTVA
Q4 25
6.6%
-14.1%
Q3 25
22.7%
-12.2%
Q2 25
8.9%
20.4%
Q1 25
-1.3%
14.8%
Q4 24
5.1%
-1.0%
Q3 24
22.0%
-22.5%
Q2 24
1.6%
17.2%
Q1 24
-4.0%
9.3%
EPS (diluted)
CCL
CCL
CTVA
CTVA
Q4 25
$0.33
$-0.80
Q3 25
$1.33
$-0.47
Q2 25
$0.42
$1.92
Q1 25
$-0.06
$0.95
Q4 24
$0.28
$-0.05
Q3 24
$1.26
$-0.76
Q2 24
$0.07
$1.51
Q1 24
$-0.17
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCL
CCL
CTVA
CTVA
Cash + ST InvestmentsLiquidity on hand
$1.9B
$4.5B
Total DebtLower is stronger
$27.4B
$1.7B
Stockholders' EquityBook value
$12.3B
$24.1B
Total Assets
$51.7B
$42.8B
Debt / EquityLower = less leverage
2.23×
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCL
CCL
CTVA
CTVA
Q4 25
$1.9B
$4.5B
Q3 25
$1.8B
$2.6B
Q2 25
$2.1B
$2.1B
Q1 25
$833.0M
$2.0B
Q4 24
$1.2B
$3.2B
Q3 24
$1.5B
$2.5B
Q2 24
$1.6B
$2.0B
Q1 24
$2.2B
$1.7B
Total Debt
CCL
CCL
CTVA
CTVA
Q4 25
$27.4B
$1.7B
Q3 25
$27.2B
$1.7B
Q2 25
$28.0B
$1.7B
Q1 25
$27.7B
$1.8B
Q4 24
$28.2B
$2.0B
Q3 24
$29.6B
$2.0B
Q2 24
$30.2B
$2.5B
Q1 24
$31.6B
$2.5B
Stockholders' Equity
CCL
CCL
CTVA
CTVA
Q4 25
$12.3B
$24.1B
Q3 25
$11.9B
$25.2B
Q2 25
$10.0B
$25.9B
Q1 25
$9.2B
$24.3B
Q4 24
$9.3B
$23.8B
Q3 24
$8.6B
$24.7B
Q2 24
$6.8B
$25.2B
Q1 24
$6.7B
$24.8B
Total Assets
CCL
CCL
CTVA
CTVA
Q4 25
$51.7B
$42.8B
Q3 25
$50.8B
$42.2B
Q2 25
$51.2B
$41.8B
Q1 25
$48.5B
$42.1B
Q4 24
$49.1B
$40.8B
Q3 24
$49.8B
$41.9B
Q2 24
$49.6B
$41.5B
Q1 24
$49.8B
$43.6B
Debt / Equity
CCL
CCL
CTVA
CTVA
Q4 25
2.23×
0.07×
Q3 25
2.28×
0.07×
Q2 25
2.79×
0.07×
Q1 25
3.02×
0.07×
Q4 24
3.05×
0.08×
Q3 24
3.45×
0.08×
Q2 24
4.43×
0.10×
Q1 24
4.72×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCL
CCL
CTVA
CTVA
Operating Cash FlowLast quarter
$1.5B
$4.4B
Free Cash FlowOCF − Capex
$12.0M
$4.2B
FCF MarginFCF / Revenue
0.2%
106.2%
Capex IntensityCapex / Revenue
23.8%
5.7%
Cash ConversionOCF / Net Profit
3.61×
TTM Free Cash FlowTrailing 4 quarters
$2.6B
$2.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCL
CCL
CTVA
CTVA
Q4 25
$1.5B
$4.4B
Q3 25
$1.4B
$193.0M
Q2 25
$2.4B
$947.0M
Q1 25
$925.0M
$-2.1B
Q4 24
$911.0M
$4.2B
Q3 24
$1.2B
$130.0M
Q2 24
$2.0B
$451.0M
Q1 24
$1.8B
$-2.6B
Free Cash Flow
CCL
CCL
CTVA
CTVA
Q4 25
$12.0M
$4.2B
Q3 25
$736.0M
$36.0M
Q2 25
$1.5B
$829.0M
Q1 25
$318.0M
$-2.2B
Q4 24
$319.0M
$4.0B
Q3 24
$628.0M
$-24.0M
Q2 24
$720.0M
$337.0M
Q1 24
$-370.0M
$-2.8B
FCF Margin
CCL
CCL
CTVA
CTVA
Q4 25
0.2%
106.2%
Q3 25
9.0%
1.4%
Q2 25
24.4%
12.8%
Q1 25
5.5%
-49.9%
Q4 24
5.4%
100.4%
Q3 24
8.0%
-1.0%
Q2 24
12.5%
5.5%
Q1 24
-6.8%
-61.4%
Capex Intensity
CCL
CCL
CTVA
CTVA
Q4 25
23.8%
5.7%
Q3 25
7.9%
6.0%
Q2 25
13.4%
1.8%
Q1 25
10.4%
2.1%
Q4 24
10.0%
4.6%
Q3 24
7.3%
6.6%
Q2 24
22.8%
1.9%
Q1 24
39.5%
3.3%
Cash Conversion
CCL
CCL
CTVA
CTVA
Q4 25
3.61×
Q3 25
0.75×
Q2 25
4.23×
0.72×
Q1 25
-3.23×
Q4 24
3.01×
Q3 24
0.69×
Q2 24
22.16×
0.43×
Q1 24
-6.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCL
CCL

Cruise Passenger Ticket$4.1B64%
Other$2.2B34%
Cruise$90.0M1%
Tour And Other$29.0M0%

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

Related Comparisons